Search - tctmd.com

Displaying 41 - 60 of 62

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

News Daily News

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Shelley Wood

December 10, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

News Daily News

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Todd Neale

September 13, 2018

News Daily News

Valsartan Recall Expanded by FDA and European Medicines Agency

Shelley Wood

August 10, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

Shelley Wood

August 01, 2018

News Daily News

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Michael O'Riordan

July 16, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

News Daily News

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

Michael O'Riordan

October 18, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Michael H. Wilson

June 28, 2016

News Daily News

Si se Tomaran Más INRA, podrían Salvarle la Vida a Casi 30.000 Pacientes Cada Año

Michael H. Wilson

June 28, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies Las Directrices Europeas y Norteamericanas sobre Insuficiencia Cardíaca Abogan por el Uso de 2 Nuevos Tratamientos

L.A. McKeown

May 24, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Daily News

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

Todd Neale

July 13, 2015

Advertisement

TCTMD’s Top 10 Most Popular Stories for July 2019

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Valsartan Recall Expanded by FDA and European Medicines Agency

TCTMD’s Top 10 Most Popular Stories for July 2018

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Generic ARBs Linked to Increased Adverse Events

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

La AHA Facilita las Interacciones Farmacológicas entre Estatinas y Fármacos contra la Enfermedad Cardiovascular

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Si se Tomaran Más INRA, podrían Salvarle la Vida a Casi 30.000 Pacientes Cada Año

US and European Heart Failure Guidelines Advocate Use of Two New Therapies Las Directrices Europeas y Norteamericanas sobre Insuficiencia Cardíaca Abogan por el Uso de 2 Nuevos Tratamientos

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content